Caxton

Latest statistics and disclosures from Caxton Corp's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Caxton consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Caxton Corp

Caxton Corp holds 11 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Xeris Pharmaceuticals (XERS) 64.4 $11M -9% 5.1M 2.21
 View chart
Rezolute Com New (RZLT) 19.2 $3.4M 1.3M 2.55
 View chart
Spdr S&p 500 Etf Tr Tr Unit (SPY) 5.5 $971k +40% 1.9k 523.16
 View chart
Berkshire Hathaway Inc Del Cl B New (BRK.B) 2.4 $428k 1.0k 420.32
 View chart
Kyverna Therapeutics (KYTX) 2.2 $394k NEW 16k 24.84
 View chart
Molecular Templates Com New (MTEM) 1.7 $307k 137k 2.24
 View chart
Mind Medicine Mindmed Com New (MNMD) 1.6 $273k NEW 29k 9.40
 View chart
Abivax Sa Sponsored Ads (ABVX) 1.3 $226k -5% 16k 14.30
 View chart
Lexeo Therapeutics (LXEO) 0.9 $162k 10k 15.68
 View chart
Compass Therapeutics (CMPX) 0.5 $86k 44k 1.98
 View chart
Adicet Bio (ACET) 0.2 $41k NEW 18k 2.35
 View chart

Past Filings by Caxton Corp

SEC 13F filings are viewable for Caxton Corp going back to 2013

View all past filings